ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Texts Of Workshop Report Summarized

November 8, 1996

To Industry for Development, NDA

November 18, 1977

Avon Awards $50 Million To NCI And Three Centers.

October 12, 2001

Sen. Dole Raps HEW Over Delays On Patent Requests

August 11, 1978

Plaza Dedicated At NIH In Honor Of Paul Rogers.

June 15, 2001

Computer-Aided Detection Approved For Mammograms.

December 14, 2001